首页 | 本学科首页   官方微博 | 高级检索  
检索        

海鞘来源放线菌Streptomyces pratensis SCSIO LCY05中skyllamycins的发现及其生物合成分析
引用本文:李艳青,凌春耀,易湘茜,高程海,鞠建华,马俊英.海鞘来源放线菌Streptomyces pratensis SCSIO LCY05中skyllamycins的发现及其生物合成分析[J].中国海洋药物,2021,40(3):1-14.
作者姓名:李艳青  凌春耀  易湘茜  高程海  鞠建华  马俊英
作者单位:中国科学院南海海洋研究所 中国科学院热带海洋生物资源与生态重点实验室 广东省海洋药物重点实验室;中国科学院大学,中国科学院南海海洋研究所 中国科学院热带海洋生物资源与生态重点实验室;广西中医药大学 药学院 海洋药物研究院,广西中医药大学 药学院 海洋药物研究院,广西中医药大学 药学院 海洋药物研究院,中国科学院南海海洋研究所 中国科学院热带海洋生物资源与生态重点实验室 广东省海洋药物重点实验室;中国科学院大学,中国科学院南海海洋研究所 中国科学院热带海洋生物资源与生态重点实验室广东省海洋药物重点实验室;中国科学院大学
基金项目:国家自然科学(31870046,82022067) ;国家自然科学基金-山东联合(U1706206) ;广东省促进经济发展专项资金 (海洋经济发展用途) 项目 (GDME-2018C003, GDNRC[2020]070) ;广东省自然科学(2018A0303130005) ;广东特支计划”本土创新创业团队项目 (2019BT02Y262) ;南方海洋科学与工程广东省实验室(广州)人才团队引进重大专项 (GML2019ZD0406) 。
摘    要:目的 挖掘海鞘来源放线菌 Streptomyces pratensis SCSIO LCY05生产含肉桂酰独特结构单元的skyllamycins类环肽的潜能,并深入分析skyllamycins生物合成基因簇的新特征.方法 利用Illumina Hiseq和Pacbio SMRT测序平台对S.pratensis SCSI...

关 键 词:S.pratensis  SCSIO  LCY05  肉桂酰结构单元  skyllamycins  生物合成基因簇  缩合/异构化结构域
收稿时间:2020/12/31 0:00:00
修稿时间:2021/2/23 0:00:00

Discovery and biosynthetic analysis of skyllamycins from Streptomyces pratensis SCSIO LCY05 derived from Ascidian
JU Jian-hua and.Discovery and biosynthetic analysis of skyllamycins from Streptomyces pratensis SCSIO LCY05 derived from Ascidian[J].Chinese Journal of Marine Drugs,2021,40(3):1-14.
Authors:JU Jian-hua and
Institution:CAS Key Laboratory of Tropical Marine Bio-resources and Ecology,Guangdong Key Laboratory of Marine Materia Medica,South China Sea Institute of Oceanology;China;Chinese Academy of Sciences;China,
Abstract:Objective To investigate the potential of cinnamyl structural unit containing skyllamycins production in Streptomyces pratensis SCSIO LCY05 derived from ascidian and analyze the new characteristics of skyllamycins biosynthetic gene cluster (skl BGC). Methods The whole genome of S. pratensis SCSIO LCY05 was sequenced using the Illumina Hiseq and PacBio SMRT platform, and the biosynthetic gene clusters of the secondary meatbolites were predicted and the functions of ORFs in the biosynthetic gene cluster were annotated by online bioinformatic softwares. The one strain many compounds (OSMAC) strategy was used to conduct the fermentation optimization of S. pratensis SCSIO LCY05. The secondary metabolites of the strain were isolated and structurally characterized by extraction, chromatography and spectroscopic data analyses, etc. The biosynthetic pathway and novel biosynthetic characteristics of the obtained compounds were analyzed. Results The whole genome sequencing results showed that the genome size of S. pratensis SCSIO LCY05 is 8.42 Mbp, containing a total of 35 biosynthetic gene clusters. The 20th gene cluster on the genome is 95% similar to the reported skyllamycins biosynthetic gene cluster and predicted to charge for the biosynthesis of cinnamyol unit containing natural products in S. pratensis SCSIO LCY05. Based on the OSMAC strategy, two peaks with typical absorption characteristics were found in SCAS medium of S. pratensis SCSIO LCY05, which were identified as skyllamycin A and skyllamycin B. The biosynthetic pathway of skyllamycin A and B was analyzed in detail. Further sequence alignment indicated that the C11 domain on skyllamycin assembly line is a special domain with dual functions that responsible for the condensation and epimerization of the 11th amino acid in skyllamycin. Concluison In this study, we found that thecyclic peptides skyllamycins can be produced in S. pratensis SCSIO LCY05 by OSMAC strategy, and discovered new characteristics in its biosynthetic assembly line. Notably, this study also provided a new strain resource for the indepth elucidation of the biosynthetic mechanism of skyllamycins and subsequent development and utilization.
Keywords:S  pratensis SCSIO LCY05  cinnamoyl structural unit  skyllamycins  biosynthetic gene cluster  condensation/epimerization domain
点击此处可从《中国海洋药物》浏览原始摘要信息
点击此处可从《中国海洋药物》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号